US generic drug firm Amneal to tap India market
The company, founded by a US citizen of Indian origin Chirag Patel and family, will be bringing to the Indian market an innovative medicine portfolio for oncology and CNS therapy to begin with.
The company, founded by a US citizen of Indian origin Chirag Patel and family, will be bringing to the Indian market an innovative medicine portfolio for oncology and CNS therapy to begin with.
